MedicaidPrior AuthMedium impact
GLP-1 Shortage
Missouri Medicaid (MO HealthNet)·MO · Family Medicine, Internal Medicine, Endocrinology·Provider Notice
Effective date
Feb 20, 2024
We identified it
Jun 20, 2026
Summary
Due to ongoing GLP-1 medication shortages, MO HealthNet is instructing providers to avoid submitting prior authorization requests for non-preferred GLP-1 agonists when the reason is solely supply shortages. Instead, providers should substitute with preferred GLP-1 agonists (Victoza, Trulicity, Byetta) or preferred DPP-4 inhibitors.
Action Required
Immediately: Providers must stop submitting PA requests for non-preferred GLP-1 agonists when solely due to shortage issues. Instead, substitute with preferred alternatives: Victoza (liraglutide), Trulicity (dulaglutide), or Byetta (exenatide) for GLP-1 options, or preferred DPP-4 inhibitors including Janumet, Januvia, Jentadueto, Kombiglyze XR, Onglyza, or Tradjenta. Update clinical protocols to reflect these preferred alternatives during shortage periods.